Advertisement

Topics

Altus Capital Partners buys ChoiceSpine

05:46 EST 21 Nov 2018 | SmartBrief

Altus Capital Partners has paid an undisclosed amount for spinal fusion hardware and biologics company ChoiceSpine.  -More

Original Article: Altus Capital Partners buys ChoiceSpine

NEXT ARTICLE

More From BioPortfolio on "Altus Capital Partners buys ChoiceSpine"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Biotherapeutics
The field encompassing therapeutic materials produced using biological means, including recombinant DNA technology. Biotherapeutics, also known as biotech drugs or biologics, are therapies derived from living organisms. By harnessing these living cells...